Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection

被引:32
|
作者
Speth, C [1 ]
Pichler, I [1 ]
Stöcki, G [1 ]
Mir, M [1 ]
Dierich, MP [1 ]
机构
[1] Univ Innsbruck, Inst Hyg, A-6020 Innsbruck, Austria
基金
奥地利科学基金会;
关键词
D O I
10.1016/S0171-2985(98)80071-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transmembranous urokinase-type plasminogen activator receptor (uPAR; CD87) focuses the formation of active plasmin at the cell surface, thus enhancing directional extracellular proteolysis. Since proteolysis is involved in processes like adhesion, chemotaxis and migration which are important for viral spreading, rye investigated the expression of uPAR in HIV-infected cells. Expression of CD87 was upmodulated in U937 monocytic cells as well as in the T cell line H9 and in peripheral blood mononuclear cells (PBMC), both on protein and on mRNA level. This upmodulation was not caused by enhanced mRNA stability but by an enhanced transcriptional rate of the CD87 gene as shown by nuclear run-on analysis. To identify the HN-responsive element in the CD87 promoter we investigated the promoter activity in U937 and H9 cells at different time points after HIV-infection. Although the transcription of the CD87 gene is higher in HIV-infected cells the promoter activity declines after infection, indicating the presence of an additional regulatory element located upstream of the known promoter sequence or in intron sequences.
引用
收藏
页码:152 / 162
页数:11
相关论文
共 50 条
  • [31] Urokinase plasminogen activator receptor (uPAR) signaling and physical association with integrins on the surface of NK cells
    Gellert, GC
    Goldfarb, RH
    Kitson, RP
    FASEB JOURNAL, 2003, 17 (07): : C287 - C287
  • [32] Urokinase plasminogen activator receptor (uPAR) and integrin α5β1 regulate plasminogen activator inhibitor-1 (PAI-1) activity in medulloblastoma cells
    Nalla, Arun Kumar
    Asuthkar, Swapna
    Gujrati, Meena
    Dinh, Dzung H.
    Rao, Jasti S.
    CANCER RESEARCH, 2012, 72
  • [33] Design and biological activity of new high-affinity ligands for the urokinase-type plasminogen activator receptor (CD87)
    Schmiedeberg, N
    Bürgle, M
    Wilhelm, O
    Lottspeich, F
    Graeff, H
    Schmitt, M
    Magdolen, V
    Kessler, H
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 543 - 545
  • [34] Expression of urokinase type plasminogen activator receptor (uPAR) in the bovine oviduct: Relationship with uPA effect on oviductal epithelial cells
    Garcia, D. C.
    Miceli, D. C.
    Valdecantos, P. A.
    Garcia, E. V.
    Roldan-Olarte, M.
    RESEARCH IN VETERINARY SCIENCE, 2014, 97 (01) : 118 - 123
  • [35] Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87)
    Boris K. Pliyev
    Molecular and Cellular Biochemistry, 2009, 321 : 111 - 122
  • [36] Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87)
    Pliyev, Boris K.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 321 (1-2) : 111 - 122
  • [37] Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
    Achim Krüger
    Rita Soeltl
    Verena Lutz
    Olaf G Wilhelm
    Viktor Magdolen
    Elena E Rojo
    Petros A Hantzopoulos
    Henner Graeff
    Bernd Gänsbacher
    Manfred Schmitt
    Cancer Gene Therapy, 2000, 7 : 292 - 299
  • [38] Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
    Krüger, A
    Soeltl, R
    Lutz, V
    Wilhelm, OG
    Magdolen, V
    Rojo, EE
    Hantzopoulos, PA
    Graeff, H
    Gänsbacher, B
    Schmitt, M
    CANCER GENE THERAPY, 2000, 7 (02) : 292 - 299
  • [39] Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1
    Jamaluddin, Md. Saha
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (02) : 618 - 627
  • [40] BUTYRATE AFFECTS THE EXPRESSION OF THE UROKINASE PLASMINOGEN-ACTIVATOR (UPA) AND ITS RECEPTOR (UPAR) GENES IN COLON-CANCER CELLS
    DANG, JJ
    WANG, Y
    DOE, WF
    GASTROENTEROLOGY, 1994, 106 (04) : A380 - A380